H

Horizon Research Group LLC | Coral Gables, FL

Research site

(Unclaimed)

Location

717 Ponce De Leon Boulevard, Suite 301, Coral Gables, Florida, United States of America

Site insights

Top conditions

Top treatments

Clazakizumab

BI 690517

VX-147

RDX013

RGLS8429

APL-2

MK-2060

Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling

Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease in Patients With ESKD

Drug: Placebo

Drug: CSL300

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling

Proteinuric Kidney Disease

Drug: Placebo

Drug: VX-147